Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Awards
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
    • Women in Healthcare
    • - Luminaries
    • - Top 25 Diversity Leaders
    • - Leaders to Watch
    • - Luminaries
    • - Top 25 Women Leaders
    • - Women to Watch
  • Events
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Custom Media Event: ESG Summit
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Social Determinants of Health Symposium
    • Leadership Symposium
    • Health Care Hall of Fame Gala
    • Top 25 Women Leaders Gala
    • Best Places to Work Awards Gala
    • Top 25 Diversity Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Strategic Marketing
    • - Virtual Health
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Government
December 17, 2018 12:00 AM

Trump freeze on NIH fetal tissue use puts disease research in limbo

Steven Ross Johnson
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Getty Images
    Dr. Christian Hinrichs, assistant clinical investigator at the Center for Cancer Research at the National Cancer Institute, helped develop advanced, cutting-edge procedures to cure two women of a rare form of cervical cancer.

    The Trump administration has reportedly put a freeze on the procurement of human fetal tissue by NIH scientists, leaving the future of HIV and cancer research in question and researchers concerned whether this signaled the first step toward a more extensive ban.

    Since September, National Institutes of Health researchers haven't been able to procure new human fetal tissue to conduct experiments as HHS launched an audit of the nature of the procurements. The development was first reported in Science magazine.

    In its announcement at that time, the agency stated it was canceling its contract with California-based Advanced Bioscience Resources, a provider of fetal tissue for the Food and Drug Administration, out of concerns there were not "appropriate protections applicable to fetal tissue research."

    In an email response, HHS spokeswoman Caitlyn Oakley pointed out that the move applied only to scientists on NIH's staff, and that researchers were asked to notify NIH leaders if new supplies of human fetal tissue were needed to prevent disruptions in current projects. She said there has been no pause in procurement of human fetal tissue among outside laboratories that receive NIH funding.

    "The intent was never to cause research to stop," Oakley said. "NIH is currently assessing if there are other NIH intramural research projects that require procurement of new fetal tissue to determine appropriate next steps to prevent interruption of research."

    But the temporary ban does impact outside labs that are working in collaboration with NIH-staffed scientists, according to Dr. Walter Greene, director of the Gladstone Center for HIV Cure Research at the University of California at San Francisco.

    He said current work on a possible HIV cure has been pushed back several months ever since the HHS announced its ban in September because his lab is working with researchers at the National Institute of Allergy and Infectious Diseases' Rocky Mountain Laboratories in Hamilton, Mont.

    "That just knocked the legs off the table of our research," Greene said about the fetal tissue ban.

    After the ban was put in place, researchers at Rocky Mountain first learned that they could request to procure more fetal tissue when they read about it in news reports; they were not directly notified by NIH, according to Greene.

    They currently have supplies for one experiment. Even if Rocky Mountain is approved to procure additional fetal tissue, the delay has set back work until at least April.

    Many view the move as a response to anti-abortion supporters' calls to end research using human fetal tissue because it creates a market for human body parts.

    In September, 85 Republican House members wrote a letter to the FDA objecting to its contract with Advanced Bioscience.

    "Unborn children are not commodities to be bought and sold," the letter said. "The practice of conducting research using the body parts of children whose lives have been violently ended by abortion is abhorrent."

    Researchers agree that there are no current alternatives to fetal tissue for research on diseases like HIV or cancer. The cells that form at that stage of human development have different properties than ones at later stages.

    Greene said the current ban affects a relatively small number of researchers. But he worried what could happen if the administration decided to expand the ban to all labs that receive NIH funding.

    "There will be a lot of people who will be really upset if it goes to include the extramural program," Greene said.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Ezike 800.jpg
    Former Illinois health chief Ezike under scrutiny by state's top ethics investigator
    AHRQ Director Robert Valdez in front of American flag
    Q&A: AHRQ chief aims to help communities improve their health systems
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Nominate/Eligibility
      • 100 Most Influential People
      • 50 Most Influential Clinical Executives
      • Best Places to Work in Healthcare
      • Excellence in Governance
      • Health Care Hall of Fame
      • Healthcare Marketing Impact Awards
      • Top 25 Emerging Leaders
      • Top 25 Innovators
      • Diversity in Healthcare
        • - Luminaries
        • - Top 25 Diversity Leaders
        • - Leaders to Watch
      • Women in Healthcare
        • - Luminaries
        • - Top 25 Women Leaders
        • - Women to Watch
    • Events
      • Conferences
        • Transformation Summit
        • Women Leaders in Healthcare Conference
        • Social Determinants of Health Symposium
        • Leadership Symposium
      • Galas
        • Health Care Hall of Fame Gala
        • Top 25 Women Leaders Gala
        • Best Places to Work Awards Gala
        • Top 25 Diversity Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Strategic Marketing
        • - Virtual Health
      • Webinars
      • Custom Media Event: ESG Summit
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing